-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Photo: Jonathan Backer, M.
Image source: Albert Einstein School of Medicine
Breast cancer is a major public health problem in the United States, associated with more than 40,000 deaths each year, most of which are caused by cancer metastasis, that is, the spread of cancer to other parts of
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), awarded Jonathan Backer, MD, professor and president of molecular pharmacology at the Albert Einstein School of Medicine and associate director of shared resources at the Montefiore Einstein Cancer Center (MECC), a five-year, $10 million team science grant (P01) to study research in the lungs (key metastatic sites of breast cancer).
"The lack of receptors that we can target in the treatment of other types of breast cancer is a huge challenge for patients and clinicians," said
In conducting their research, Dr.
Three funded projects: A project led by Dr.
